| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-06-23 |
4 |
AS |
$35.30 |
$220,625 |
D/D |
(6,250) |
16,975 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-09-15 |
4 |
AS |
$37.32 |
$233,250 |
D/D |
(6,250) |
15,933 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-09-15 |
4 |
OE |
$21.01 |
$131,313 |
D/D |
6,250 |
22,183 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2021-03-15 |
4 |
D |
$78.39 |
$584,789 |
D/D |
(7,460) |
110,855 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2012-04-20 |
4 |
AS |
$35.00 |
$269,185 |
D/D |
(7,691) |
28,920 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-11-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,833) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-05-23 |
4 |
AS |
$67.16 |
$584,981 |
D/D |
(8,710) |
44,364 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-15 |
4 |
D |
$94.53 |
$892,647 |
D/D |
(9,443) |
133,061 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-18 |
4 |
AS |
$94.09 |
$902,982 |
D/D |
(9,597) |
136,304 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
19,375 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-08-10 |
4 |
OE |
$21.01 |
$210,100 |
D/D |
10,000 |
28,334 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-08-10 |
4 |
S |
$32.00 |
$320,011 |
D/D |
(10,000) |
18,334 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2012-04-25 |
4 |
AS |
$31.64 |
$316,432 |
D/D |
(10,000) |
10,416 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2012-04-25 |
4 |
OE |
$2.76 |
$27,600 |
D/D |
10,000 |
20,416 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2012-11-05 |
4 |
AS |
$46.00 |
$460,000 |
D/D |
(10,000) |
52,277 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2012-11-05 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
62,277 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-05-22 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
64,973 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-07-01 |
4 |
AS |
$60.00 |
$600,000 |
D/D |
(10,000) |
43,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-07-01 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
53,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-09-05 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
53,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-09-05 |
4 |
AS |
$70.00 |
$700,000 |
D/D |
(10,000) |
43,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-09-19 |
4 |
OE |
$11.05 |
$110,500 |
D/D |
10,000 |
53,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-09-19 |
4 |
AS |
$80.19 |
$801,900 |
D/D |
(10,000) |
43,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-02-03 |
4 |
AS |
$67.70 |
$676,966 |
D/D |
(10,000) |
42,350 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-02-03 |
4 |
OE |
$21.51 |
$215,100 |
D/D |
10,000 |
52,350 |
0 |
- |
|
294 Records found
|
|
Page 8 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
